With the OHIP Plus finally kicking in, I wonder if there have been any unintended consequences that we are just starting to realize. Many have argued it is a political move from the Liberal party to secure a “sure win” in the upcoming election. Others may see it as a step toward a Universal Pharmacare in Canada. One way or another, its intention is to allow all children and youth under the age of 25 in Ontario to have access to prescription medications without any barriers.
I have ranted about drug shortages in the past. It is extremely frustrating that medications go on drug shortage with little warning, or when drug shortages occur, simple modification of the therapy isn’t an option.
Happy New Year! As we begin the year of 2018, there are few things that I want to work on professionally. But the main mission is to focus on delivering values beyond the script.
As 2017 comes to an end, I want to reflect on some of the highlights for my blog.
First, here are my top 10 most commonly viewed posts or pages:
If you live in Ontario, OHIP Plus will be effective as of Jan 1, 2018 which means the Ontario Drug Benefits Program will pay for a number of prescription medications for anyone below the age of 25. So what do you really need to know?
Recently, many primary health providers have been bombarded with questions about the latest shingles vaccine, Shringrix made by GlaxoSmithKline.
Recently, I have come across few treatment modalities that have been classified as medical devices, when I think they fit more appropriately as medications. So I start to wonder what are some of the benefits when a treatment is considered as a medical device? Continue reading Medical Device or Medication?